Bli medlem
Bli medlem

Du är här

2022-07-22

Redeye: Sdiptech - Solid Overall with a Few Soft Units

Redeye retains its positive view on Sdiptech following a Q2 report beating our forecasts with 5%. We believe organic sales and EBITA growth will rebound, which we believe will reduce the increased discount to peers. We leave our Base Case unchanged.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments


Sdiptech - Solid Overall with a Few Soft Units

Författare MFN